摘要
目的:通过医药上市公司并购方式和企业主要财务指标分析,探讨适合我国医药企业发展的并购方式。方法:利用财务收益评价法对企业并购前后的主要业绩进行分析比较。结果:横向并购方式的主要财务指标较为理想,纵向并购方式的主要财务指标较差。结论:我国医药企业应该采用横向并购方式来推动企业的整合发展。
Objective ： To explore suitable approaches to mergers for the development of pharmaceutical enterprises through analyzing changes in major financial indicators of the listed pharmaceutical enterprises. Methods： The major M＆A performances before and after mergers were analyzed by comparing the financial revenue. Results： Horizontal mergers＇s major financial indicators were better than other approaches. Vertical mergers＇s major financial indicators were worse than other approaches. Conclusions： Chinese pharmaceutical enterprises should adopt horizontal mergers approach to promote enterprises＇ intergration.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2009年第4期286-289,共4页
Chinese Journal of New Drugs
关键词
医药企业
并购方式
效应
pharmaceutical enterprises
mergers approaches
effect
